Degree of blood pressure reduction and recurrent stroke: The PROGRESS trial

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 85, Issue 11, 2014, Pages 1284-1285

  Arima, Hisatomi ^a   Anderson, Craig ^a   Omae, Teruo ^b   Woodward, Mark ^a   MacMahon, Stephen ^a,c   Mancia, Giuseppe ^d   Bousser, Marie Germaine ^e   Tzourio, Christophe ^f,g   Harrap, Stephen ^h   Liu, Lisheng ⁱ   Neal, Bruce ^a   Chalmers, John ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d SAN GERARDO HOSPITAL   (Italy)

^e HÔPITAL LARIBOISIÈRE   (France)

^f INSERM   (France)

^g UNIVERSITÉ DE BORDEAUX   (France)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; PERINDOPRIL;

BLOOD PRESSURE; COMPLICATION; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; STROKE;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PERINDOPRIL; RECURRENCE; RISK FACTORS; STROKE;

EID: 84900355083     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2014-307856     Document Type: Article

References (6)

1. Ovbiagele B, Diener HC, Yusuf S, et al.; for the PROFESS Investigators. Level of systolic blood pressure within the normal range and risk of recurrent stroke. JAMA 2011;306:2137-44.
2. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood pressure lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
3. Arima H, Chalmers J. PROGRESS: prevention of recurrent stroke. J Clin Hypertens (Greenwich) 2011;13:693-702.
4. Arima H, Chalmers J, Woodward M, et al.; for the PROGRESS Collaborative Group. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens 2006;24:1201-8.
5. Staessen JA, Wang JG, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet 2001;358:1305-15.
6. The SPS3 Study Group. Blood-pressure targets in patients with recent lacunar stroke: the SPS3 randmised trial. Lancet 2013;382:507-15.